Prolifera is dedicated to redefining the future of the cannabis industry during these uncertain times. Built around a line of cutting edge instant release tablets, Prolifera produces all new cannabis products made using familiar oil based pharmaceutical technology. This delivery method offers consumers a consistent baseline dose of rare, minor cannabinoids in a instant release tablet form.
The tablets come in 50mg full spectrum formulas, each tablet color coded and easily halved to allow consumers to mix and match cannabinoids according to their individual needs; if someone needs help with multiple maladies, they no longer have to rely on just one option but a diverse range of plant derived concentrates. With little studies available for cannabis benefits because of prohibition, Prolifera is built to provide a consistent method for individuals to discover their own customized wellness formula that works for their body.
Due to cannabinoids and cannabis in general being illegal to research for almost 80 years, many consumers are familiar with cannabidiol (CBD), but are mystified by minor cannabinoids that have the potential to provide other results. Recent Federal Legalization changes have allowed us to begin researching individual cannabinoids. The cannabis plant has hundreds! We have only identified a dozen or so. Prolifera has three facilities working on the frontier of cannabis science and developing new minor cannabinoids to provide never before seen data.
Currently, Prolifera carries CBD+CBG and CBD+CBN formulas as well as terpene enriched CBD. CBC coming soon. Educational content on each minor cannabinoid and the hemp derived terpenes coming soon.
Shop Prolifera, and discover your baseline today.